跳至主要内容
临床试验/TCTR20180414001
TCTR20180414001Enrolling By Invitation未知

Efficacy and adverse drug reaction between Risperidone solution local made and original drug in treatment of autism spectrum disorders

o0 个研究点目标入组 60 人开始时间: 2018年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
Enrolling By Invitation
发起方
o
入组人数
60
Efficacy and adverse drug reaction between ... | 临床试验